Development and Initial Validation of the Novel Scale for Assessing Quality of Life of Prostate Cancer Patients Receiving Androgen Deprivation Therapy

BACKGROUND: There has been no a specific scale to measure quality of life (QOL) for prostate cancer patients receiving androgen deprivation therapy (ADT) to date. This study aimed to develop and initially validate the scale to evaluate QOL for prostate cancer patients receiving ADT. METHODS: The sca...

Descripción completa

Detalles Bibliográficos
Autores principales: Dun, Yao-Jun, Liu, Hui-Xin, Yu, Lu-Ping, Li, Qing, Zhang, Xiao-Wei, Tang, Xu, Qin, Cai-Peng, Xu, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5586177/
https://www.ncbi.nlm.nih.gov/pubmed/28836552
http://dx.doi.org/10.4103/0366-6999.213416

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5586177/
https://www.ncbi.nlm.nih.gov/pubmed/28836552
http://dx.doi.org/10.4103/0366-6999.213416

Ejemplares similares